| P50 | author | Mathias Mericskay | Q56892299 |
| | Kylie M Georgas | Q114400304 |
| | Melissa Little | Q41179909 |
| | David Sassoon | Q42667418 |
| P2093 | author name string | Isabelle Gross | |
| | Patricia D Wilson | |
| | Jonathan D Licht | |
| | Debra J Morrison | |
| | Deborah P Hyink | |
| | Seiyu Hosono | |
| | Milton A English | |
| P2860 | cites work | CRIM1, a novel gene encoding a cysteine-rich repeat protein, is developmentally regulated and implicated in vertebrate CNS development and organogenesis | Q22011105 |
| | WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis | Q24292676 |
| | Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression | Q24316570 |
| | sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways | Q24336220 |
| | The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins | Q24534190 |
| | Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling | Q24534484 |
| | Distinct but overlapping expression patterns of two vertebrate slit homologs implies functional roles in CNS development and organogenesis | Q28144856 |
| | Sprouty, an intracellular inhibitor of Ras signaling. | Q52569025 |
| | Wilms tumor and the WT1 gene | Q28203445 |
| | Morpholino antisense oligomers: design, preparation, and properties | Q28243074 |
| | WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts | Q28505651 |
| | Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation | Q28505657 |
| | Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation | Q28509874 |
| | WT-1 is required for early kidney development | Q28512266 |
| | Evidence that SPROUTY2 functions as an inhibitor of mouse embryonic lung growth and morphogenesis | Q28585209 |
| | Conserved function of mSpry-2, a murine homolog of Drosophila sprouty, which negatively modulates respiratory organogenesis | Q28592618 |
| | Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells | Q28609619 |
| | Kidney morphogenesis: cellular and molecular regulation | Q33855366 |
| | The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin | Q33874404 |
| | Cross-talk in kidney development | Q34026941 |
| | Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. | Q34100782 |
| | The candidate Wilms' tumour gene is involved in genitourinary development | Q34189819 |
| | Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway. | Q34460141 |
| | Identifying differences in mRNA expression by representational difference analysis of cDNA | Q35004368 |
| | A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1 | Q36560249 |
| | Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product | Q38298155 |
| | Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control | Q38325277 |
| | Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence | Q38338176 |
| | Xenopus Sprouty2 inhibits FGF-mediated gastrulation movements but does not affect mesoderm induction and patterning | Q40423955 |
| | WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin | Q40767021 |
| | Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation | Q40787356 |
| | Analysis of WT1 target gene expression in stably transfected cell lines | Q41002837 |
| | Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. | Q41084039 |
| | Growth factor requirements of organogenesis in serum-free metanephric organ culture | Q41385346 |
| | Detection of messenger RNA by in situ hybridization. | Q41587073 |
| | E-cadherin is a WT1 target gene | Q42832537 |
| | Polypeptide growth factors in metanephric growth and segmental nephron differentiation | Q44118632 |
| | mSprouty2 inhibits FGF10-activated MAP kinase by differentially binding to upstream target proteins | Q44133728 |
| | A novel method for real time quantitative RT-PCR. | Q46544663 |
| | Cloning and expression pattern of a mouse homologue of drosophila sprouty in the mouse embryo | Q47963291 |
| | The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. | Q48369257 |
| | Exogenous FGF-4 can suppress anterior development in the mouse embryo during neurulation and early organogenesis. | Q52169044 |
| | Expression of sprouty2 during early development of the chick embryo is coincident with known sites of FGF signalling. | Q52170367 |
| | Architectural patterns in branching morphogenesis in the kidney. | Q52567180 |
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 41420-41430 | |
| P577 | publication date | 2003-07-25 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development | |
| P478 | volume | 278 | |